Determinants of inhibitor development in previously treated hemophilia A patients

被引：0
|
作者：
Iorio, A. [1 ,2 ]
Barbara, A. [3 ]
Castaman, G. [4 ]
Fischer, K. [5 ]
Gilman, E. [6 ]
Goudemand, J. [7 ]
Kavakli, K. [8 ]
Kubicek-Hofmann, C. [9 ]
Lambert, T. [10 ]
Lissitchkov, T.
Makris, M. [6 ]
Matthew, P. [11 ]
Castelano, M. E. M.
Ozdemir, N.
Parra, R.
Peerlinck, K.
Rivolta, G. [12 ]
Romanov, V [13 ]
Roussel-Robert, V
Tagliaferri, A. [14 ]
Windyga, J. [15 ]
Zanon, E. [16 ]
机构：
[1] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4L8, Canada
[2] McMaster Univ, Med, Hamilton, ON, Canada
[3] McMaster Univ, Clin Epidemiol & Biostat, Hamilton, ON, Canada
[4] Azienda Osped Policlin Careggi, Florence, Italy
[5] Van Creveld Clin, Utrecth, Netherlands
[6] Univ Sheffield, Sheffield, S Yorkshire, England
[7] Univ Lille, Lille, France
[8] Unviers Izmir, Izmir, Turkey
[9] Univ Berlin, Berlin, Germany
[10] Univ Paris, F-75252 Paris, France
[11] Bayer, Pittsburgh, PA USA
[12] Policlin Univ, Parma, Italy
[13] Baxter Healthcare, Los Angeles, CA USA
[14] Policlin Univ, Parma, Italy
[15] Univ Warsaw, Warsaw, Poland
[16] Univ Padua Polyclin, Padua, Italy
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OR144
引用
下载
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [41] INCIDENCE OF INHIBITOR DEVELOPMENT IN HEMOPHILIA-A PATIENTS
    DEBIASI, R
    ROCINO, A
    PAPA, ML
    SALERNO, E
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1103 - 1103
  • [42] The PUP-GCP Clinical Trial: A Low Inhibitor Rate in Previously Untreated Patients with Severe Hemophilia a Treated with Octanate
    Knaub, Sigurd
    Klukowska, Anna
    Komrska, Vladimir
    Laguna, Pawel
    Vladimir, Vdovin
    Jansen, Martina
    BLOOD, 2014, 124 (21)
  • [43] Inhibitor development in patients with hemophilia: An overview.
    Leissinger, Cindy A.
    SEMINARS IN HEMATOLOGY, 2006, 43 (02) : S1 - S2
  • [44] Recommendations for authors of manuscripts reporting inhibitor cases developed in previously treated patients with hemophilia: communication from the SSC of the ISTH
    Iorio, A.
    Barbara, A. M.
    Bernardi, F.
    Lillicrap, D.
    Makris, M.
    Peyvandi, F.
    Rosendaal, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (08) : 1668 - 1672
  • [45] Inhibitor development in relation to treatment duration in severe hemophilia A in previously untreated patients: results from the sippet trial
    Peyvandi, F.
    Mannucci, P. M.
    Garagiola, I
    Anzoletti, M. B.
    El-Beshlawy, A.
    El-Alfy, M.
    Madatha, V. R.
    Eshghi, P.
    Varadarajan, R.
    Hanagavadi, S.
    Karimi, M.
    Manglani, M., V
    Ross, C.
    Young, G.
    Seth, T.
    Apte, S.
    Nayak, D.
    Santagostino, E.
    Mancuso, E.
    Gonzalez, A. C. S.
    Owaidah, Tarek M.
    Rosendaal, F. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 321 - 322
  • [46] Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A
    Gouw, S. C.
    van den Berg, H. M.
    le Cessie, S.
    van der Bom, J. G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (07) : 1383 - 1390
  • [47] Inhibitor development in previously untreated patients with hemophilia A and B: A prospective 23-year follow-up
    Ettingshausen, CE
    Zyschka, A
    Oldenburg, J
    Saguer, IM
    Ehrenforth, S
    Kreuz, W
    30TH HEMOPHILIA SYMPOSIUM, 2001, : 110 - 113
  • [48] Systematic Review of the Role of FVIII Concentrates in Inhibitor Development in Previously Untreated Patients with Severe Hemophilia A: A 2013 Update
    Franchini, Massimo
    Coppola, Antonio
    Rocino, Angiola
    Santagostino, Elena
    Tagliaferri, Annarita
    Zanon, Ezio
    Morfini, Massimo
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (07): : 752 - 766
  • [49] Source and purity of factor VIII products as risk factors for inhibitor development in previously untreated patients with severe hemophilia A
    Mancuso, M.
    Mannucci, P.
    Rocino, A.
    Garagiola, I.
    Tagliaferri, A.
    Santagostino, E.
    HAEMOPHILIA, 2012, 18 : 87 - 87
  • [50] Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study
    Gouw, Samantha C.
    van der Bom, Johanna G.
    van den Berg, H. Marijke
    BLOOD, 2007, 109 (11) : 4648 - 4654
12345